Structural and phylogenetic characterization of human SLURP‐1, the first secreted mammalian member of the Ly‐6/uPAR protein superfamily
暂无分享,去创建一个
S. Wattler | W. Forssmann | G. Heine | K. Adermann | M. Meyer | F. Wattler | M. Nehls
[1] M. Ploug,et al. Localization of the Disulfide Bonds in the NH 2-terminal Domain of the Cellular Receptor for Human Urokinase-type Plasminogen Activator , 2001 .
[2] M. Loda,et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Ratnam,et al. The hydrophobic domains in the carboxyl-terminal signal for GPI modification and in the amino-terminal leader peptide have similar structural requirements. , 1998, Journal of molecular biology.
[4] M. Wu,et al. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion. , 1997, Biochemistry.
[5] M. Raida,et al. Mapping of peptides and protein fragments in human urine using liquid chromatography-mass spectrometry. , 1997, Journal of chromatography. A.
[6] M. Schrader,et al. Peptide bank generated by large-scale preparation of circulating human peptides. , 1997, Journal of chromatography. A.
[7] M. Peitsch,et al. The chemokine information source: identification and characterization of novel chemokines using the WorldWideWeb and Expressed Sequence Tag Databases , 1997, Journal of leukocyte biology.
[8] G. Fu,et al. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Raida,et al. Systematic isolation of circulating human peptides: the concept of peptide trapping. , 1996, European journal of medical research.
[10] M. Raida,et al. HCC-1, a novel chemokine from human plasma , 1996, The Journal of experimental medicine.
[11] R. Ridge,et al. Partial N-terminal amino acid sequence of the anti-neoplastic urinary protein (ANUP) and the anti-tumour effect of the N-terminal nonapeptide of the unique cytokine present in human granulocytes. , 1996, Cytokine.
[12] M. Wilm,et al. Analytical properties of the nanoelectrospray ion source. , 1996, Analytical chemistry.
[13] M. Raida,et al. GCAP‐II: Isolation and characterization of the circulating form of human uroguanylin , 1995, FEBS letters.
[14] M. Sandrin,et al. Tissue expression, structure and function of the murine Ly‐6 family of molecules , 1995, Immunology and cell biology.
[15] M. Raida,et al. hBD‐1: a novel β‐defensin from human plasma , 1995 .
[16] R. Brakenhoff,et al. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion , 1995, The Journal of cell biology.
[17] M. Raida,et al. hBD-1: a novel beta-defensin from human plasma. , 1995, FEBS letters.
[18] M. Ploug,et al. Structure—function relationships in the receptor for urokinase‐type plasminogen activator Comparison to other members of the Ly‐6 family and snake venom α‐neurotoxins , 1994 .
[19] C. M. Fletcher,et al. Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. , 1994, Structure.
[20] M. Ploug,et al. Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. , 1994, FEBS letters.
[21] U. Weidle,et al. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins. , 1993, The Journal of biological chemistry.
[22] W. Bickmore,et al. Colocalization of the human CD59 gene to 11p13 with the MIC11 cell surface antigen. , 1993, Genomics.
[23] T. Malek,et al. Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins. , 1993, Journal of immunology.
[24] M. Raida,et al. The circulating bioactive form of human guanylin is a high molecular weight peptide (10.3 kDa) , 1993, FEBS letters.
[25] P. Schulz-Knappe,et al. Characterization of natural posttranslationally processed peptides from human blood: A new tool in the systematic investigation of native peptides , 1993 .
[26] D. Fleenor,et al. Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. M. Nolan,et al. Long-range physical map of the Ly-6 complex: mapping the Ly-6 multigene family by field-inversion and two-dimensional gel electrophoresis. , 1992, Genomics.
[28] F. Blasi,et al. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. , 1991, The Journal of biological chemistry.
[29] F. Blasi,et al. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. , 1991, The Journal of biological chemistry.
[30] T. Tsuchiya,et al. Structure of the snake short-chain neurotoxin, erabutoxin c, precursor gene. , 1990, European journal of biochemistry.
[31] E. Appella,et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.
[32] M. Karas,et al. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.
[33] A. Bothwell,et al. Isolation and expression of an IFN-responsive Ly-6C chromosomal gene. , 1988, Journal of immunology.
[34] A. Bothwell,et al. Isolation of a murine Ly‐6 cDNA reveals a new multigene family. , 1986, EMBO Journal.
[35] R. Macleod,et al. Studies on an antineoplastic fraction from human urine. Characterization of the major protein in this fraction. , 1986, The Biochemical journal.